erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Tooth Fractures D014082 2 associated lipids
Tooth Diseases D014076 2 associated lipids
Onychomycosis D014009 2 associated lipids
Thyroid Crisis D013958 1 associated lipids
Thromboembolism D013923 6 associated lipids
Tachycardia, Supraventricular D013617 3 associated lipids
Tachycardia D013610 7 associated lipids
Syphilis, Latent D013592 4 associated lipids
Syphilis, Cutaneous D013591 1 associated lipids
Syphilis, Congenital D013590 3 associated lipids
Syphilis, Cardiovascular D013589 1 associated lipids
Syphilis D013587 6 associated lipids
Synovitis D013585 15 associated lipids
Surgical Wound Infection D013530 7 associated lipids
Surgical Wound Dehiscence D013529 3 associated lipids
Streptococcal Infections D013290 4 associated lipids
Stomatitis D013280 14 associated lipids
Stomach Diseases D013272 7 associated lipids
Staphylococcal Skin Infections D013207 9 associated lipids
Staphylococcal Scalded Skin Syndrome D013206 1 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Sporotrichosis D013174 3 associated lipids
Splenomegaly D013163 4 associated lipids
Splenic Infarction D013159 1 associated lipids
Skin Ulcer D012883 6 associated lipids
Skin Neoplasms D012878 12 associated lipids
Skin Diseases, Infectious D012874 7 associated lipids
Sinusitis D012852 9 associated lipids
Sigmoid Neoplasms D012811 5 associated lipids
Sialadenitis D012793 1 associated lipids
Sexually Transmitted Diseases D012749 4 associated lipids
Seizures D012640 87 associated lipids
Dermatitis, Seborrheic D012628 10 associated lipids
Sebaceous Gland Diseases D012625 1 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Scarlet Fever D012541 1 associated lipids
Scalp Dermatoses D012536 11 associated lipids
Salpingitis D012488 2 associated lipids
Rubella D012409 2 associated lipids
Rosacea D012393 13 associated lipids
Rickettsiaceae Infections D012288 2 associated lipids
Rickettsia Infections D012282 5 associated lipids
Rhinitis D012220 10 associated lipids
Rhabdomyolysis D012206 9 associated lipids
Respiratory Insufficiency D012131 10 associated lipids
Relapsing Fever D012061 3 associated lipids
Red-Cell Aplasia, Pure D012010 4 associated lipids
Rat-Bite Fever D011906 1 associated lipids
Radiodermatitis D011855 3 associated lipids
Quadriplegia D011782 4 associated lipids
Pyoderma D011711 5 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Pulmonary Emphysema D011656 3 associated lipids
Psychoses, Substance-Induced D011605 7 associated lipids
Psoriasis D011565 47 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Protein-Losing Enteropathies D011504 2 associated lipids
Prostatitis D011472 5 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Prolapse D011391 1 associated lipids
Postgastrectomy Syndromes D011178 2 associated lipids
Porphyrias D011164 2 associated lipids
Pneumonia, Staphylococcal D011023 2 associated lipids
Pneumonia, Mycoplasma D011019 6 associated lipids
Pneumonia, Pneumococcal D011018 3 associated lipids
Pneumonia D011014 10 associated lipids
Pneumococcal Infections D011008 7 associated lipids
Pleuropneumonia D011001 3 associated lipids
Pleurisy D010998 20 associated lipids
Pleural Effusion D010996 3 associated lipids
Pleural Diseases D010995 4 associated lipids
Pityriasis D010915 3 associated lipids
Pilonidal Sinus D010864 1 associated lipids
Pharyngeal Diseases D010608 4 associated lipids
Peripheral Nervous System Diseases D010523 33 associated lipids
Periodontitis D010518 22 associated lipids
Periodontal Abscess D010508 2 associated lipids
Pericoronitis D010497 2 associated lipids
Pericarditis, Constrictive D010494 1 associated lipids
Pericarditis D010493 6 associated lipids
Periapical Diseases D010483 4 associated lipids
Peptic Ulcer Hemorrhage D010438 4 associated lipids
Pemphigoid, Bullous D010391 8 associated lipids
Peliosis Hepatis D010382 1 associated lipids
Parotitis D010309 4 associated lipids
Paresthesia D010292 7 associated lipids
Parapsoriasis D010267 1 associated lipids
Papillon-Lefevre Disease D010214 1 associated lipids
Pancreatitis D010195 10 associated lipids
Pancreatic Fistula D010185 2 associated lipids
Pain, Postoperative D010149 13 associated lipids
Pain D010146 64 associated lipids
Otorhinolaryngologic Diseases D010038 3 associated lipids
Otitis Media, Suppurative D010035 4 associated lipids
Otitis Media with Effusion D010034 9 associated lipids
Otitis Media D010033 12 associated lipids
Otitis Externa D010032 8 associated lipids
Otitis D010031 5 associated lipids
Osteomyelitis D010019 10 associated lipids
Osteolysis D010014 8 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Ramirez B and Richter JE Review article: promotility drugs in the treatment of gastro-oesophageal reflux disease. 1993 Aliment. Pharmacol. Ther. pmid:8094981
Catnach SM et al. Dose-dependent stimulation of gallbladder contraction by intravenous erythromycin in man. 1993 Aliment. Pharmacol. Ther. pmid:8439638
Verhagen MA et al. Effects of a new motilide, ABT-229, on gastric emptying and postprandial antroduodenal motility in healthy volunteers. 1997 Aliment. Pharmacol. Ther. pmid:9663833
Haans JJ and Masclee AA Review article: The diagnosis and management of gastroparesis. 2007 Aliment. Pharmacol. Ther. pmid:18081647
Talley NJ et al. Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. 2000 Aliment. Pharmacol. Ther. pmid:11121915
Emmanuel AV et al. Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. 2004 Aliment. Pharmacol. Ther. pmid:15023171
Netzer P et al. Effects of ABT-229, a motilin agonist, on acid reflux, oesophageal motility and gastric emptying in patients with gastro-oesophageal reflux disease. 2002 Aliment. Pharmacol. Ther. pmid:12182748
Athanasakis E et al. Octreotide enhances the accelerating effect of erythromycin on gastric emptying in healthy subjects. 2002 Aliment. Pharmacol. Ther. pmid:12182757
McCallum RW and Cynshi O Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis - a randomized, multicentre, placebo-controlled study. 2007 Aliment. Pharmacol. Ther. pmid:17894654
Chen CL et al. Efficacy of a motilin receptor agonist (ABT-229) for the treatment of gastro-oesophageal reflux disease. 2002 Aliment. Pharmacol. Ther. pmid:11929393
Winstead NS and Wilcox CM Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage: a cost-effectiveness analysis. 2007 Aliment. Pharmacol. Ther. pmid:17848180
Brand RM et al. Transdermal delivery of erythromycin lactobionate--implications for the therapy of gastroparesis. 1997 Aliment. Pharmacol. Ther. pmid:9218087
Annese V et al. Cisapride and erythromycin prokinetic effects in gastroparesis due to type 1 (insulin-dependent) diabetes mellitus. 1997 Aliment. Pharmacol. Ther. pmid:9218089
van Erpecum KJ et al. Review article: agents affecting gall-bladder motility--role in treatment and prevention of gallstones. 2000 Aliment. Pharmacol. Ther. pmid:10903008
Chiba T et al. Motilides accelerate regional gastrointestinal transit in the dog. 2000 Aliment. Pharmacol. Ther. pmid:10886053
Ehrenpreis ED et al. Which form of erythromycin should be used to treat gastroparesis? A pharmacokinetic analysis. 1998 Aliment. Pharmacol. Ther. pmid:9690728
Jameson JS et al. Oral or intravenous erythromycin has no effect on human distal colonic motility. 1992 Aliment. Pharmacol. Ther. pmid:1420750
Curry JI et al. Review article: erythromycin as a prokinetic agent in infants and children. 2001 Aliment. Pharmacol. Ther. pmid:11328252
Boecxstaens V et al. Modulation of the postprandial acid and bile pockets at the gastro-oesophageal junction by drugs that affect gastric motility. 2011 Aliment. Pharmacol. Ther. pmid:21517922
Laine L et al. Prospective evaluation of the macrolide antibiotic dirithromycin for the treatment of Helicobacter pylori. 1996 Aliment. Pharmacol. Ther. pmid:8791949
Wehrmann T et al. Effect of erythromycin on human biliary motility. 1996 Aliment. Pharmacol. Ther. pmid:8791972
BOURICHON J [Importance of the suppository form in the administration of propionyl-erythromycin to children]. 1962 Alger Medicale pmid:13871918
LEBON J et al. [Staphylococcal diarrhea after terramycin administration; cure by erythromycin]. 1955 Alger Medicale pmid:14398597
Thornton JB and Harris JH The prevention of bacterial endocarditis. A new approach to a changing disease. 1986 Ala J Med Sci pmid:3953983
Simakova MG et al. [Clinical aspects, diagnosis and treatment of intrauterine infections]. 1995 Akush Ginekol (Mosk) pmid:7485765
Mezinova NN et al. [Effect of anti-chlamydial drugs on the effectiveness of the treatment of habitual abortion]. 1991 Akush Ginekol (Mosk) pmid:1951968
Mezinova NN and Chuchupalov PD [Endometrial Chlamydia infection in women with habitual abortion]. 1992 Akush Ginekol (Mosk) pmid:1476220
Kotua EN and Moroz AF [Erythromycin-ascorbinate therapy of pregnant rats with staphylococcal infections caused by staphylococcal strains both sensitive and resistant to erythromycin]. 1971 Akush Ginekol (Mosk) pmid:5138198
Kotua EN and Moroz AF [Passage of erythromycin and ristomycin into blood, placenta, fetus and amniotic fluid during various stages of pregnancy in generalized staphylococcal infection in albino rats]. 1971 Akush Ginekol (Mosk) pmid:4328638
Moss AA et al. Radiologic and clinical assessment of broad-spectrum antibiotic therapy in Crohn's disease. 1978 AJR Am J Roentgenol pmid:101028
Stickney RH et al. Chlamydia trachomatis: a cause of an infantile pneumonia syndrome. 1978 AJR Am J Roentgenol pmid:101061
Lauenstein TC et al. Time-resolved three-dimensional MR imaging of gastric emptying modified by IV administration of erythromycin. 2003 AJR Am J Roentgenol pmid:12704042
Wagner CM The care and management of pertussis in pediatric patients. 2001 Mar-Apr Air Med. J. pmid:11250611
Warning against using erythromycin (even orally) while using protease inhibitors or certain other drugs. 2004 AIDS Treat News pmid:15595151
Schlecht HP et al. Images in HIV/AIDS. HIV-associated lymphogranuloma venereum proctitis. 2007 AIDS Read pmid:17396331
Berger TG and Koehler JE Bacillary angiomatosis. 1993-1994 AIDS Clin Rev pmid:8217903
van der Wouw PA et al. Disseminated cat-scratch disease in a patient with AIDS. 1989 AIDS pmid:2515881
Taha TE et al. A phase III clinical trial of antibiotics to reduce chorioamnionitis-related perinatal HIV-1 transmission. 2006 AIDS pmid:16816561
Takei M et al. [Studies on the mixed culture of Candida and Lactobacillus. 3. Influences of the antibiotics (EM and TM)]. 1967 Aichi Gakuin Daigaku Shigakkai Shi pmid:5236280
Sugiyama H [Experimental studies on control of dental caries. 1. Preventive effect of Erythromycin]. 1967 Aichi Gakuin Daigaku Shigakkai Shi pmid:5244796
Sugiyama H [Experimental studies on control of dental caries. 2. Erythromycin and oral microbial flora]. 1968 Aichi Gakuin Daigaku Shigakkai Shi pmid:5261349
Chen SZ et al. [Correlation of HERG K+ channel protein expression to chemosensitivity of tumor cells to doxorubicin and its modulation by erythromycin]. 2005 Ai Zheng pmid:16086867
Hashiba H et al. Transformation of Lactobacillus helveticus subsp. jugurti with plasmid pLHR by electroporation. 1990 Agric. Biol. Chem. pmid:1368569
LIGNY G and VIGUIE R [DESTRUCTION OF THE INTESTINAL FLORA BY ANTIBIOTIC THERAPY]. 1964 May-Jun Agressologie pmid:14185522
Friedman GD and Selby JV Epidemiological screening for potentially carcinogenic drugs. 1990 Agents Actions Suppl. pmid:2316434
Carević O and Djokić S Comparative studies on the effects of erythromycin A and azithromycin upon extracellular release of lysosomal enzymes in inflammatory processes. 1988 Agents Actions pmid:2847507
Campbell G et al. A cautionary tale: delayed onset rhabdomyolysis due to erythromycin/simvastatin interaction. 2007 Age Ageing pmid:17913761
Haboubi NY et al. Duodenal mucosal morphometry of elderly patients with small intestinal bacterial overgrowth: response to antibiotic treatment. 1991 Age Ageing pmid:2028847
Roddis MJ Antibiotic-associated colitis: a retrospective study of fifteen cases. 1978 Age Ageing pmid:101026
Olatunji FO et al. Non-gonococcal bacterial agents of conjunctivitis and their antibiotic susceptibility patterns in Ilorin, Nigeria. 2007 Afr J Med Med Sci pmid:18390064